FIELD: medicine; allergology.
SUBSTANCE: method of allergen-specific immunotherapy efficiency evaluation applied for children implies immune-enzyme analysis for cytokine - TNF-α and IFN-γ in blood serum after 4-week course of allergen-specific immunotherapy followed with calculation of concentration ratio. If ratio value is less or equal to 3.0 immunotherapy is considered to be effective, while coefficient value is more than 3.0 indicates no effect of immunotherapy.
EFFECT: reliable evaluation of allergen-specific immunotherapy efficiency applied for children's bronchial asthma at early stage of therapy to provide well-timed and adequate correction of therapy.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING CHRONIC RECURRENT ALLERGIC DISEASES OF NASAL MUCOSA AND PARANASAL SINUSES BY ENDONASAL AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2411048C1 |
| METHOD FOR EVALUATING EFFECTIVENESS OF TREATMENT OF BRONCHIAL ASTHMA | 2008 |
|
RU2389023C2 |
| METHOD OF TREATMENT OF ATOPIC DERMATITIS IN CHILDREN | 2006 |
|
RU2348423C2 |
| METHOD OF TREATMENT OF BRONCHIAL ASTHMA | 2017 |
|
RU2652752C1 |
| METHOD FOR TREATING ATOPIC BRONCHIAL ASTHMA | 2003 |
|
RU2236849C2 |
| METHOD FOR PREVENTION OF EXACERBATION OF BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016 |
|
RU2625744C1 |
| METHOD OF TREATING ALLERGIC DISEASES BY AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2395305C1 |
| METHOD FOR PREDICTION OF THERAPEUTIC EFFICACY OF SEVERE BRONCHIAL ASTHMA | 2013 |
|
RU2530616C1 |
| METHOD OF SELECTING DURATION OF THE THERAPEUTIC COURSE WITH CERULOPLASMIN IN PATIENTS WITH BRONCHIAL ASTHMA | 2015 |
|
RU2603468C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CHRONIC RHINOSINUSITIS IN CHILDREN | 2023 |
|
RU2816051C1 |
